"It's a common side effect" is one of the most frustrating things a doctor can say to a family member who just watched their elderly father nearly go down in the hallway at 2AM. Common does not mean acceptable. And in an older adult, dizziness from sleep medication is not a nuisance to manage around — it's a direct pathway to a fall, and a fall at his age can mean a fracture, a hospitalization, or worse.
The good news is that getting off sleep medication safely is entirely possible. There is a clinical pathway for it, a structured program that makes deprescribing significantly easier than going cold turkey, and an evidence base that shows most older adults sleep as well or better after completing it. Here's what you need to know.
Most sleep medications produce dizziness through a combination of mechanisms. Sedative-hypnotics like zolpidem (Ambien), temazepam (Restoril), and eszopiclone (Lunesta) work by enhancing GABA activity in the brain — the same neurotransmitter pathway that produces sedation, muscle relaxation, and reduced coordination. In younger adults with efficient liver metabolism, these effects dissipate within a predictable window. In adults over 65, where liver and kidney function has declined, the drug clears more slowly. The result is residual pharmacodynamic activity that persists into waking hours, producing exactly what your father is experiencing: dizziness, unsteadiness, slowed reactions, and impaired balance that doesn't announce itself but shows up the moment he gets out of bed.
The side effects of Ambien that patients and families should understand include next-day psychomotor impairment that is well-documented and dose-dependent — worse in older adults, worse with higher doses, and worse in combination with other CNS-active medications he may be taking for other conditions. If his sleep medication is a benzodiazepine, Xanax or similar drugs taken for insomnia carry their own long-term risks that go well beyond dizziness, including dependency, cognitive impairment, and a significantly elevated fall and fracture risk.
The dizziness your father is experiencing is the visible symptom of a broader pharmacological problem. The medication is doing more to his central nervous system than just helping him sleep — and in an older body, that surplus effect is dangerous.
Falls are the leading cause of injury-related death in adults over 65. Hip fractures alone carry a mortality risk of up to 30% in the year following the injury. Sedative-hypnotics appear consistently in research as significant independent risk factors for falls in older adults — not because they're rare, but because the balance impairment they produce is both predictable and preventable.
The dangers of sleeping pills and their common side effects covers the full risk profile, but the fall pathway is the most immediately urgent piece for your father's situation. When dizziness is present and acknowledged — even framed as "common" — the appropriate clinical response is not reassurance. It's a medication review and a plan to address the underlying insomnia differently.
A comprehensive guide to sleeping pill side effects covers the broader landscape across medication classes, which is useful context if your father has been switched between different sleep medications over the years without significant improvement in either his sleep or his side effects.
If the medication is clearly causing problems, the instinct is to stop it. That instinct is correct in direction but needs to be managed carefully in execution. Abrupt discontinuation of sedative-hypnotics — particularly benzodiazepines — can produce significant withdrawal effects: rebound anxiety, worsening insomnia, irritability, and in some cases more serious neurological effects. Even with Z-drugs like zolpidem, stopping suddenly often triggers rebound insomnia — a temporary but severe worsening of sleep that feels like proof the medication is necessary, when it's actually proof the brain has adapted to its presence.
This rebound effect is the main reason deprescribing attempts fail. The patient stops the medication, sleeps terribly for several nights, concludes the medication was the only thing keeping them functional, and restarts. Without something running in parallel to support sleep behaviorally, the taper almost always collapses.
The clinical solution is to begin a structured behavioral sleep program concurrently with the taper — so that as the medication dose decreases, a non-pharmacological sleep architecture is being built to replace it. This is exactly what CBT-I does, and exactly why it is the recommended approach for medication-dependent insomnia in older adults.
Cognitive Behavioral Therapy for Insomnia is the first-line recommended treatment for chronic insomnia according to the American College of Physicians, the American Academy of Sleep Medicine, and the NIH. It is more effective than sleep medication in long-term outcomes and specifically designed to address the behavioral and cognitive patterns that keep insomnia running — the patterns that medication suppresses but never resolves.
For someone in your father's situation — on sleep medication, experiencing side effects, wanting to stop but worried about losing the sleep he has — CBT-I provides exactly the bridge needed. Whether CBT-I can help someone taper off sleep medication is a question with a clear answer: yes, and the evidence specifically supports this combination approach. The clinician-backed path to safely tapering off prescription sleep aids outlines how a structured program changes the deprescribing equation.
Learning what CBT-I involves dispels the common misconception that it's generic sleep hygiene advice repackaged. The active components are specific and clinically validated: sleep restriction therapy, which consolidates fragmented sleep by temporarily compressing time in bed; stimulus control, which rebuilds the conditioned association between bed and sleep that erodes over months of medicated nights; and cognitive restructuring, which addresses the anxiety and hyperarousal that medication has been masking rather than resolving.
The 3 P's model of insomnia — predisposing, precipitating, and perpetuating factors — is worth understanding because it explains why your father is still on medication: the perpetuating factors that are maintaining his insomnia were never treated. Medication addressed the symptom. CBT-I addresses the cause.
For older adults specifically, the evidence is robust. A randomized controlled trial published in JAMA found CBT-I produced significantly greater improvements in sleep efficiency and total sleep time in older adults compared to controls, with sustained effects at follow-up. No fall risk. No dizziness. No drug interactions. No rebound when the program ends.
A safe taper from sleep medication in an older adult is typically slow, supervised, and run in parallel with a behavioral program. The general framework — though his physician should manage the specific schedule — involves reducing the dose incrementally over several weeks, moving slowly enough that the nervous system can adapt without triggering severe withdrawal or rebound. For benzodiazepines, this process often takes longer than families expect: months rather than weeks for someone with significant dependence.
Whether CBT-I can work for someone already taking sleep medications addresses the practical question of starting a behavioral program before the taper is complete — the answer is yes, and this is actually the recommended sequence. Start the CBT-I program first, establish some behavioral sleep architecture, then begin reducing the medication dose once the program is underway.
Trazodone versus Ambien and how they compare is relevant if his doctor suggests switching rather than tapering — a common intermediate step. The comparison is worth understanding so your family can evaluate that conversation critically.
Sleep Reset is a clinician-backed digital sleep program that delivers personalized CBT-I with real coach support. It was built specifically for people who are stuck in the medication cycle — who have been on sleep drugs for months or years, who are experiencing side effects, and who want a clinically sound way off that doesn't leave them worse than before.
The CBT-I-based program adapts in real time to your father's specific sleep patterns, adjusting the sleep window and pacing the behavioral components based on his actual sleep diary data week by week. He works with a trained sleep coach throughout — not an automated chatbot, not a passive content library, but structured human support that makes the hard early weeks of sleep restriction significantly more manageable.
Patient reviews of Sleep Reset consistently describe people who came in on medication they'd been taking for years, skeptical that anything behavioral could work after that long, and found meaningful improvement within four to six weeks of starting the program. The combination of structured CBT-I and sleep coaching is precisely what research supports for medication-dependent insomnia — not generic advice, not a wellness app, but a clinical intervention.
Sleep Reset accepts major insurance plans and operates entirely via telehealth. Your father doesn't need to travel, navigate a referral to a sleep specialist, or wait months for an appointment. Sleep Reset's looking-for-help page explains the intake pathway clearly, and the contact page is available for any questions about fit or coverage before getting started.
For families coordinating care, Sleep Reset's provider referral pathway also allows his physician to be involved directly — which is particularly important if benzodiazepine tapering needs medical supervision alongside the behavioral program.
While the longer-term work of tapering and CBT-I gets underway, there are immediate environmental and behavioral changes that reduce dizziness risk right now.
His bedroom and the path to the bathroom should be assessed for fall hazards: rugs that slide, furniture in the path, inadequate night lighting. A nightlight with a motion sensor between his bedroom and bathroom is a simple intervention with a meaningful impact. Sitting at the edge of the bed for a full 30 seconds before standing — allowing blood pressure to stabilize — can reduce orthostatic dizziness specifically. These are not fixes for the medication problem, but they are harm-reduction steps while the real solution is implemented.
Waking up at night and the causes worth understanding can help your family understand whether his nighttime waking has underlying contributors — sleep apnea, blood sugar changes, pain, urinary urgency — that deserve attention alongside the medication review. Why people wake up multiple times during the night covers the physiological landscape in plain language.
If his nighttime waking involves anxious or confused arousal — waking disoriented, not knowing where he is — confusional arousal and what to know about waking up confused is worth reading, as this is sometimes a direct effect of sedative-hypnotics in older adults rather than an independent symptom.
You are entitled to ask specific questions, and naming the right clinical concepts in that conversation matters.
Ask whether his current sleep medication is listed on the American Geriatrics Society Beers Criteria and what the practice's policy is for Beers-flagged medications in patients over 65. Ask for a structured tapering plan with a defined end date, not indefinite continuation with monitoring. Ask whether a referral to a CBT-I program is appropriate as a concurrent intervention to support the taper. And ask whether obstructive sleep apnea has been ruled out — it is significantly underdiagnosed in older adults and frequently presents as insomnia and nighttime waking that looks like medication failure rather than an undiagnosed breathing disorder.
Which telehealth platforms offer insurance-covered sleep care including CBT-I gives you specific language and options to bring to that appointment.
Your father's dizziness is not a side effect to live with. It is a signal that the treatment causing it is not appropriate for his age and physiology, and that a safer, more effective alternative exists and is accessible.
Getting off sleep medication safely requires two things: a properly supervised taper and a concurrent behavioral program that builds real sleep where the medication used to be. CBT-I does the second part — and does it durably, without the risks that have sent you looking for answers in the first place.
Sleep Reset is the program built for this. Start there.
Dr. Areti Vassilopoulos | Psychologist | Sleep Medicine Expert
Dr. Vassilopoulos is the Clinical Content Lead for Sleep Reset and Assistant Professor at Yale School of Medicine. She has co-authored peer-reviewed research articles, provides expert consultation to national nonprofit organizations, and chairs clinical committees in pediatric health psychology for the American Psychological Association. She lives in New England with her partner and takes full advantage of the beautiful hiking trails.
Fax: +1 (984) 888-8385
.jpg)
.jpeg)